Cargando…
Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
Drug-induced liver injury (DILI) is a rare but potentially severe adverse drug event, which is also a major cause of study cessation and market withdrawal during drug development. Since no acknowledged diagnostic tests are available, DILI diagnosis poses a major challenge both in clinical practice a...
Autores principales: | Weber, Sabine, Gerbes, Alexander L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181520/ https://www.ncbi.nlm.nih.gov/pubmed/35682731 http://dx.doi.org/10.3390/ijms23116049 |
Ejemplares similares
-
Update on herbal and dietary supplement-induced liver injury: current gaps and future directions
por: Weber, Sabine, et al.
Publicado: (2023) -
Acute liver injury in a patient with adult-onset Still’s disease—the challenge of differential diagnosis
por: Weber, Sabine, et al.
Publicado: (2020) -
Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
por: Weber, Sabine, et al.
Publicado: (2020) -
Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event
por: Weber, Sabine, et al.
Publicado: (2021) -
A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)